Search: 13th Annual Meeting Attendees
Results 1 - 20 of 20

Stephen Valerio

Global Publications Director, OBU, Global Medical Affairs
AstraZeneca

Type of Company:
Pharmaceutical
Professional Degrees: CMPP, MS
CMPP Certified: (9/2014)

Bio: Stephen Valerio is the Therapeutic Area Director for Oncology Publications at AstraZeneca. A Certified Medical Publication Planner and a member of the International Society for Medical Publication Professionals (ISMPP), he has previously served as a member and co-chair of the ISMPP Education Committee and was a member of the Consultation Panel for the Good Publication Practice 2 Guidelines. He has over 15 years of experience in medical publications as a medical writer and working in strategic publications management. Stephen has worked on both national and international publication plans and supported multiple global launches. He has extensive experience in the areas of oncology, psychiatry, neurology, HIV, HCV and metabolism. Prior to joining AstraZeneca, Stephen worked in at Genentech/Roche in a variety of therapeutic areas and has also led the publication planning and scientific services groups at several medical education agencies. Stephen has a MS in Biology from Yale University and a BA with Honors in Biology from Drew University.

Jennifer Van Ekelenburg

Head, Clinical Governance and Data Transparency, Global Medical
GlaxoSmithKline

Type of Company:
Pharmaceutical

Bio: Jen has twenty years of experience in R&D at GlaxoSmithKline (GSK). In her current role, she leads a global team responsible for supporting GSK's enterprise medical governance boards focused on Human Subject Research and Data Disclosure, as well as, Pharma Data Transparency operations. Most recently Jen has led a team to establish the Human Subject Research Medical Governance Board and is Deputy Chair of the Data Disclosure Board. Prior to her current role, Jen's experience includes clinical submissions to regulatory authorities, risk management, systems validation, information systems project management, training the organisation on clinical processes and clinical data management.

Rozena Varghese

Associate Scientific Director
ICON plc

Type of Company:
Communications Agency
Professional Degrees: CMPP, PharmD
CMPP Certified: (9/2015)

Lana Vegman

Associate Director, Scientific Communications and Publications, Medical Affairs
Retrophin, Inc

Type of Company:
Pharmaceutical
Professional Degrees: PharmD
CMPP Certified: (3/2018)

Neil Venn

Associate Scientific Director
Prime Global

Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
Other Degrees*: MRes, BSc
CMPP Certified: (3/2017)

Roseann Ventimiglia

Sr. Director, Medical Affairs
Celldex Therapeutics

Type of Company:
Biotechnology
Professional Degrees: PhD

Joanne Walker

Senior Manager, Publishing Solutions, Business Development
Future Science Group

Type of Company:
Publisher
Professional Degrees: BA/BS

Debbie Walton

Publication Manager, Global Scientific and Medical Publications
Merck

Type of Company:
Pharmaceutical
Professional Degrees: MBA, MS

Yaming Wang

Senior Scientific Director, Medical
Prime Global

Type of Company:
Communications Agency

Cindy Wang

Scientific Communication Specialist
OTSUKA Pharmaceutical Development & Commercialization, Inc

Type of Company:
Pharmaceutical
Professional Degrees: MS

Tracy Wetter

Director, Publications and Scientific Communications, Global Medical Affairs
Incyte Corporation

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, PhD
CMPP Certified: (3/2011)

Beth Whann

Director, Publications Management, External Medical Communications
Pfizer Inc

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, ELS
CMPP Certified: (9/2010)

Bio: As a Publications Specialist in the External Medical Communications group at Pfizer, Beth Whann supports the development and implementation of publication plans for products across a range of therapeutic areas and advises publication teams on current publication policies and industry trends. In her role, Beth applies expertise from over 20 years of editorial and project management experience in medical communications and science education publishing with companies including Wyeth, PeerView Institute for Medical Education, Curatio, ApotheCom, and Harcourt College Publishers. She received her bachelor¿s degree in biology from Yale University and is certified as an Editor in the Life Sciences and a Certified Medical Publication Professional. Beth serves on the Medical Publishing Insights & Practices (MPIP) steering committee, is a member of the American Medical Writers Association (AMWA), and holds an elected position as voting member of the International Society for Medical Publication Professionals (ISMPP) Certification Board for the 2016-2018 term.

Richard White

Chief Operating Officer
Oxford PharmaGenesis Ltd

Type of Company:
Communications Agency
Professional Degrees: MA, PhD

Bio: Richard White is Chief Operating Officer at Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 20 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, and has personally authored more than 20 journal publications. Richard has published white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, is an invited author of articles for ISMPP's MAP e-newsletter, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice and communications expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies and academic institutions, and has delivered invited presentations, educational webinars and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP and TIPPA Annual Meetings, the World Orphan Drug Congress, and the Patient Summit. Richard was Chair of the 2017 and 2018 TIPPA Annual Meetings. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator's Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is a member of Green Templeton College, University of Oxford, UK.

Susan Wingeron

President
SciStrategy Communications

Type of Company:
Communications Agency
Professional Degrees: BA/BS, MBA
CMPP Certified: (2/2009)

Shannon Winters

Senior Director, Publications, Medical Affairs
Sun Pharma

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, MS
Other Degrees*: CIC
CMPP Certified: 3/2015

Eric Wittbrodt

Director, Health Economics and Outcomes Research
AstraZeneca

Type of Company:
Pharmaceutical

Bio: Eric is Director, Health Economics and Outcomes Research for Metabolics at AstraZeneca in Wilmington, DE. Eric received his Doctor of Pharmacy degree from the University of Michigan and subsequently completed residencies at Thomas Jefferson University Hospital and the Philadelphia College of Pharmacy and Science and a fellowship in critical care at the University of Minnesota. In 2013, he earned a Master's in Public Health Leadership from the University of North Carolina at Chapel Hill. For 12 years Eric was faculty at the University of the Sciences in Philadelphia and achieved the rank of Associate Professor of Clinical Pharmacy; he was also a clinical pharmacist in the Medical Intensive Care Unit at the Hospital of the University of Pennsylvania and then at Hahnemann University Hospital. During the subsequent 10 years, Eric was employed by TAP/Takeda and Daiichi Sankyo in various field roles in Medical Affairs, including MSL, Field Scientific Lead, and most recently Executive Health Outcomes Liaison before joining AstraZeneca in early 2016.

Benjamin Wolfe

Asst. Director, Global Medical Publications
AbbVie, Inc.

Type of Company:
Pharmaceutical

Eric Wong

Associate Director, Medical Communications, Janssen Infectious Diseases
Janssen Therapeutics

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS, CMPP, HS/GED, MBA, MS, PhD
CMPP Certified: 9/2014

Bio: Eric leads the medical communications team within the infectious disease franchise at Janssen Scientific Affairs, and is responsible for the planning/execution of medical publications, development of materials for field-based medical staff, and review/approval of educational grants and charitable contributions. Eric is actively involved with ISMPP, serving as the committee chair for its newsletter, the Map. Prior to joining Pharma, he served as a researcher and reviewer at the Food and Drug Administration Center for Biologics Evaluation and Research. Eric earned his PhD in Chemical and Biomolecular Engineering from the University of Pennsylvania and MBA from Northeastern University.

Shelby Woods

Manager, Global Publications, Medical Affairs

Type of Company:
Pharmaceutical
Professional Degrees: CMPP, HS/GED
Other Degrees*: PMP
CMPP Certified: (3/2018)

Louise Wyhopen

Dir. Global Scientific Communications, Oncology Global Medical Affairs
Novartis

Type of Company:
Pharmaceutical
Professional Degrees: BA/BS
Other Degrees*: RN
CMPP Certified: (9/2010)